Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Bander ED, Kocharian G, Liechty B, Tsiouris AJ, Schwartz TH. Spontaneous regression of a clival chordoma. Case report. Acta Neurochir (Wien). 2020;162(2):433-436.

Geyer JT, Margolskee E, Krichevsky SA, Cattaneo D, Boiocchi L, Ronchi P, et al. Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression. Haematologica. 2020;105(5):e221-e224.

Schwartz Z, Magro CM. Intralesional overlap syndrome: Sclerodermic lupus panniculitis and sclerodermic discoid lupus erythematosus. JAAD Case Rep. 2020;6(3):166-168.

Fiore D, Cappelli LV, Broccoli A, Zinzani PL, Chan WC, Inghirami G. Peripheral T cell lymphomas: from the bench to the clinic. Nat Rev Cancer. 2020;20(6):323-342.

Mondello P, Tadros S, Teater M, Fontan L, Chang AY, Jain N, et al. Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma. Cancer Discov. 2020;10(3):440-459.

Patel AP, Schatz-Siemers NF, Dilcher TL, Goyal A. The interpretation of high-grade squamous intraepithelial lesion on anal cytology: a comparative analysis with the cervical Papanicolaou test. J Am Soc Cytopathol. 2020;9(6):540-549.

Patel N, Cricco-Lizza E, Kasabwala K, Xu C, Robinson BD, Khani F, et al. Corrigendum to 'The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy' [European Urology Oncology 1 (2018) 263-267]. Eur Urol Oncol. 2020;3(3):394.

Youn T, Al'Aref SJ, Narula N, Salvatore S, Pisapia D, Dweck MR, et al. F-Sodium Fluoride Positron Emission Tomography/Computed Tomography in Ex Vivo Human Coronary Arteries With Histological Correlation. Arterioscler Thromb Vasc Biol. 2020;40(2):404-411.

Ghione P, Faruque P, Mehta-Shah N, Seshan V, Ozkaya N, Bhaskar S, et al. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma. Blood Adv. 2020;4(19):4640-4647.

Gross MD, Marks LS, Sonn GA, Green DA, Wang GJ, Shoag JE, et al. Reply by Authors. J Urol. 2020;203(3):536.